Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer [Phase 2]
Open-label Phase 2 trial evaluating lenvatinib with pembrolizumab or lenvatinib with pembrolizumab and FLOT as neoadjuvant/adjuvant therapy …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors [Phase 1, Phase 2]
This clinical trials update notes ongoing Phase 1/2 studies of EIK1005, a Werner helicase inhibitor, as monotherapy and in combination with …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer [Phase 2]
This clinical trial update reports a Phase 2 study using dynamic circulating tumor DNA monitoring to guide systemic therapy in gastric cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 dose-determining study of EXS74539 (REC-4539) in participants with select solid tumors, current…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Nutrition Intervention Trials in Linxian Follow-up Study
This update reports the completion of nutrition intervention trials within the Linxian follow-up study on esophageal and gastric cancer, spo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment [Phase 3]
ClinicalTrials.gov entry for a Phase 3 study of BL-M05D1 vs investigator's choice in CLDN18.2-positive advanced gastric cancer or gastroesop…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: The UGIRA International Registry for RAMIG for Gastric Cancer
Clinical Trial Update for the UGIRA International Registry for RAMIG in gastric cancer. Recruitment is ongoing at the Chinese University of …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
This Clinical Trials update describes the FAST-GO prospective study evaluating physical function in adults receiving systemic therapy for st…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial of neoadjuvant durvalumab plus docetaxel, oxaliplatin and S-1 followed by surgery, with adjuvant durvalumab plus S-1, in poten…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression [Phase 2]
A Phase 2, single-arm exploratory trial evaluating a triple combination of anlotinib, TQB2450, and the SOX chemotherapy regimen as first-lin…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating sintilimab with bevacizumab and XELOX/SOX in initially unresectable AFP-positive gastric/GEJ adenocarcinom…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating docetaxel, oxaliplatin, and S-1 in patients with unresectable locally advanced or lymph node–limited me…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: 18F-FAPI PET/CT and MRI in Gastric Cancer
A clinical trial evaluating 18F-FAPI PET/CT and MRI in gastric cancer, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer [Phase 2]
A Phase 2 clinical trial update examining whether beta-blockers can influence the efficacy of neoadjuvant immunotherapy in gastric cancer, c…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation [NA]
This entry provides a feasibility study update on magnetic sentinel lymph node mapping for upper gastrointestinal cancers, focusing on gastr…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and activity of S095029 in combination therapy for advanced gas…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum [Phase 1, Phase 2]
Phase 1/2 window-of-opportunity study evaluating intraperitoneal TROP2 CAR/IL-15 TGFBR2 KO natural killer (NK) cells for managing gastric ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer [Phase 2]
Phase 2 clinical trial update on zolbetuximab (IMAB362) in adults with gastric cancer, including pharmacokinetic data and current non-recrui…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) [Phase 3]
This is a Phase 3 clinical trial evaluating the efficacy and safety of ferric carboxymaltose in patients with advanced gastric cancer; the s…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC [Phase 2]
A Phase 2 trial evaluating trastuzumab in combination with capecitabine and cisplatin in patients with tissue HER2-negative but serum HER2-p…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer [Phase 3]
This entry reports a Phase 3 clinical trial evaluating zolbetuximab in combination with pembrolizumab and chemotherapy for gastric cancer an…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) [Phase 1, Phase 2]
This document describes Substudy 06D of a Phase 1/2 clinical trial evaluating pembrolizumab in combination therapies for second-line gastroe…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating dynamic ctDNA-guided adjuvant therapy for stage III and IV gastric or gastroesophageal junction adenocarcinoma; cur…